FMTX NASDAQ
Forma Therapeutics Holdings, Inc.
1W: +0.3%
1M: +0.4%
3M: +126.9%
1Y: +11.2%
$20.01
Last traded 2022-10-13 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$0
+0.0% ▲
Gross Profit
$0
+0.0% ▲
Operating Income
-$173M
-39.1% ▼
Net Income
-$173M
-145.6% ▼
EPS (Diluted)
$-4.21
-38.0% ▼
EBITDA
-$171M
-73.2% ▼
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2018 | FY2019 | FY2020 | FY2021 |
|---|---|---|---|---|
| Revenue | $164M | $101M | $0 | $0 |
| YoY Growth | +0.0% | -38.7% | -100.0% | +0.0% |
| Cost of Revenue | $0 | $0 | $0 | $0 |
| Gross Profit | $164M | $101M | $0 | $0 |
| Gross Margin | 100.0% | 100.0% | — | — |
| R&D Expenses | $133M | $111M | $93M | $126M |
| SG&A Expenses | $22M | $24M | $31M | $48M |
| Operating Expenses | $154M | $136M | $124M | $174M |
| Operating Income | $10M | -$40M | -$124M | -$173M |
| Operating Margin | 5.9% | -40.2% | — | — |
| Interest Expense | $0 | $0 | $0 | $0 |
| Income Before Tax | $14M | -$37M | -$100M | -$173M |
| Tax Expense | $9M | -$2M | -$30M | $154K |
| Net Income | $5M | -$35M | -$70M | -$173M |
| Net Margin | 3.2% | -34.6% | — | — |
| EPS (Diluted) | $0.47 | $-3.06 | $-3.05 | $-4.21 |
| EBITDA | $17M | -$34M | -$99M | -$171M |
| Shares Outstanding | 11M | 11M | 23M | 41M |